The use of thiophosphonoformic acid and NRTIs to treat viral infections

Details for Australian Patent Application No. 2006220459 (hide)

Owner Adventrx Pharmaceuticals, Inc.

Inventors Waninger, Shani; Robbins, Joan; Ramos, Silvestri

Agent FB Rice

Pub. Number AU-A-2006220459

PCT Pub. Number WO2006/096859

Priority 60/659,136 07.03.05 US

Filing date 6 March 2006

Wipo publication date 14 September 2006

International Classifications

A61K 31/66 (2006.01) - Phosphorus compounds

A61K 31/505 (2006.01) - Pyrimidines

A61K 31/675 (2006.01) - having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate

Event Publications

13 September 2007 PCT application entered the National Phase

  PCT publication WO2006/096859 Priority application(s): WO2006/096859

11 February 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006220475-Compositions having sustained-release insect repellency

2006220457-Sensitive commodity depository and method of use